IO Biotech Inc

1
1
NAS:IOBT (Denmark)  
$ 1.42 -0.03 (-2.07%) 10:08 PM EST
At Loss
P/B:
0.70
Market Cap:
$ 93.55M
Enterprise V:
$ -45.17M
Volume:
73.36K
Avg Vol (2M):
94.10K
Volume:
73.36K
At Loss
Avg Vol (2M):
94.10K

Business Description

Description
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
Name Current Vs Industry Vs History
Cash-To-Debt 57.42
Equity-to-Asset 0.88
Debt-to-Equity 0.02
Debt-to-EBITDA -0.03
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -23.1
3-Year EPS without NRI Growth Rate -23.6
3-Year FCF Growth Rate -24.3

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 21.88
9-Day RSI 27.88
14-Day RSI 33.67
6-1 Month Momentum % 87.22
12-1 Month Momentum % -9.89

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.37
Quick Ratio 9.37
Cash Ratio 9.11

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -78.7
Shareholder Yield % -0.09

Financials (Next Earnings Date:2024-05-10 Est.)

IOBT's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:IOBT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

IO Biotech Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.157
Beta 0
Volatility % 89.76
14-Day RSI 33.67
14-Day ATR ($) 0.113239
20-Day SMA ($) 1.5465
12-1 Month Momentum % -9.89
52-Week Range ($) 0.8163 - 2.64
Shares Outstanding (Mil) 65.88

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

IO Biotech Inc Filings

Filing Date Document Date Form
No Filing Data

IO Biotech Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

IO Biotech Inc Frequently Asked Questions

What is IO Biotech Inc(IOBT)'s stock price today?
The current price of IOBT is $1.42. The 52 week high of IOBT is $2.64 and 52 week low is $0.82.
When is next earnings date of IO Biotech Inc(IOBT)?
The next earnings date of IO Biotech Inc(IOBT) is 2024-05-10 Est..
Does IO Biotech Inc(IOBT) pay dividends? If so, how much?
IO Biotech Inc(IOBT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1